Clinical trial
Synergistic Effect of Simvastatin and Ezetimibe on Lipid and Pro-inflammatory Profiles in Pre-diabetic Subjects
NCT01103648 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Synergistic Effect of Simvastatin and Ezetimibe on Lipid and Pro-inflammatory Profiles in Pre-diabetic Subjects
- Lead sponsor
- Federal University of São Paulo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- November 30, 2007
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk, hypercholesterolemia, inflammation, prediabetes